title: Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis.
authors.forename: Maria
authors.initials: M
authors.lastname: Antonelli
authors.forename: Manojkumar
authors.initials: M
authors.lastname: Bupathi
authors.forename: Murali
authors.initials: M
authors.lastname: Janakiram
authors.forename: Paul
authors.initials: P
authors.lastname: Hergenroeder
authors.forename: Muhammad Asim
authors.initials: MA
authors.lastname: Khan
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D053614:Janus Kinase 2 / Q000235:genetics; D008297:Male; D011086:Polycythemia / Q000139:chemically induced*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; C507924:JAK2 protein, human; D053614:Janus Kinase 2